PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environmentgrid.31147.30, Bilthoven, the Netherlands.\', \'Microvida, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.\', \'Amphia Ziekenhuis Breda, Microvida Laboratory for Microbiology, Breda, the Netherlands.\', \'Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.\', \'Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.\', \'Department of Medical Microbiology, Maastricht UMC+ and Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.\', \'Department of Medical Microbiology, Laboratory for Pathology and Medical Microbiology (PAMM), Veldhoven, the Netherlands.\', \'Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JCM.00767-21
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34191578
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34191578>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34191578>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all